Lumos Diagnostics Holdings Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Lumos Diagnostics Holdings zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 15.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)
Jan 03The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More
Jul 04Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates
Jul 12In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lumos Diagnostics Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 8 | -9 | -9 | -9 | N/A |
9/30/2023 | 9 | -9 | -9 | -9 | N/A |
6/30/2023 | 11 | -9 | -10 | -10 | N/A |
3/31/2023 | 11 | -25 | -12 | -11 | N/A |
12/31/2022 | 12 | -41 | -13 | -12 | N/A |
9/30/2022 | 12 | -43 | -18 | -15 | N/A |
6/30/2022 | 12 | -46 | -22 | -18 | N/A |
3/31/2022 | 14 | -34 | -24 | -17 | N/A |
12/31/2021 | 16 | -23 | -25 | -15 | N/A |
9/30/2021 | 17 | -19 | -22 | -13 | N/A |
6/30/2021 | 19 | -15 | -19 | -11 | N/A |
3/31/2021 | 16 | -12 | -17 | -9 | N/A |
12/31/2020 | 12 | -9 | -15 | -7 | N/A |
9/30/2020 | 9 | -9 | -13 | -6 | N/A |
6/30/2020 | 6 | -9 | -10 | -4 | N/A |
6/30/2019 | 4 | -5 | -6 | -3 | N/A |
6/30/2018 | 2 | -1 | -2 | 0 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von LDX über der Sparquote liegt (2.2%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von LDX schneller wachsen werden als der Markt Australian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von LDX in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von LDX schneller wachsen werden als der Markt von Australian.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von LDX schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von LDX in 3 Jahren voraussichtlich hoch sein wird